KARABULUT, S. Et Al. 2016. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer , vol.47, no.1 , 47-54.

KARABULUT, S., Afsar, Ç. U., Karabulut, M., Alış, H., Kılıc, L., Çikot, M., ... Yasasever, C. T.(2016). Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer , vol.47, no.1, 47-54.

KARABULUT, Senem Et Al. "Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma," Journal of Gastrointestinal Cancer , vol.47, no.1, 47-54, 2016

KARABULUT, Senem Et Al. "Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma." Journal of Gastrointestinal Cancer , vol.47, no.1, pp.47-54, 2016

KARABULUT, S. Et Al. (2016) . "Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma." Journal of Gastrointestinal Cancer , vol.47, no.1, pp.47-54.

@article{article, author={Senem KARABULUT Et Al. }, title={Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma}, journal={Journal of Gastrointestinal Cancer}, year=2016, pages={47-54} }